Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers 2022-05-09 08:04
Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board 2022-05-06 08:00
Daewoong Pharmaceutical announced first-quarter 2022 results 2022-05-05 21:00
I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act 2022-05-05 20:00
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act 2022-05-05 17:18
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma 2022-05-04 20:36
United Imaging Flips the Script on its Events Program for 2022, Reveals Expanded Sales Force and U.S. Growth 2022-05-03 23:22
Inmagene Receives FDA's IND Clearance for OX40 Antagonist 2022-05-01 06:00
IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors 2022-04-29 20:00
I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer 2022-04-29 04:01
Formosa Pharmaceuticals and AimMax Therapeutics to Present Phase 2 Trials Results of APP13007 for the Treatment after Cataract Surgery at ARVO 2022 Annual Meeting 2022-04-28 20:00
ASCO 2022 | Ascentage Pharma to Present Data from Seven Clinical Studies at the 2022 American Society of Clinical Oncology Annual Meeting 2022-04-28 08:18
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement 2022-04-27 20:30
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom 2022-04-27 19:40
Samsung Biologics Reports First Quarter 2022 Financial Results 2022-04-27 14:42
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity 2022-04-27 10:00
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study 2022-04-26 20:30
World Malaria Day: Fosun Pharma's Self-Developed Artemisinin Series Become Symbol of China's Innovative Medicines 2022-04-25 17:00
Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Cell Therapy Development for Solid Tumors 2022-04-25 11:59
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion 2022-04-21 17:00
1 78 79 80 81 82 165